Assessment of the Ki67 labeling index: a Japanese validation ring study-Reference-Cited by-同舟云学术

Assessment of the Ki67 labeling index: a Japanese validation ring study

Published:2014-05-03 Issue:1 Volume:23 Page:92-100
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Niikura Naoki,Sakatani Takashi,Arima Nobuyuki,Ohi Yasuyo,Honma Naoko,Kanomata Naoki,Yoshida Kazuya,Kadoya Takayuki,Tamaki Kentaro,Kumaki Nobue,Iwamoto Takayuki,Sugie Tomoharu,Moriya Takuya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-014-0536-0.pdf

Reference23 articles.

1. Ohno S, Chow LW, Sato N, Masuda N, Sasano H, Takahashi F, et al. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2013;142(1):69–80.

2. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–47.

3. Niikura N, Iwamoto T, Masuda S, Kumaki N, Xiaoyan T, Shirane M, et al. Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci. 2012;103:1508–12.

4. Urruticoechea A. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23:7212–20.

5. de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients. Br J Cancer. 2007;96:1504–13.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance;Breast Cancer: Basic and Clinical Research;2021-01

2. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group;JNCI: Journal of the National Cancer Institute;2020-12-28

3. Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens;Virchows Archiv;2020-05-07

4. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China;BMC Cancer;2019-10-22

5. Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort;Scientific Reports;2019-09-19